Cornell University A2201 — New York, New York

Cornell University A2201 is a clinical research site located in New York, New York, United States 10021.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

Cornell University A2201 has participated in 22 clinical trials.

Therapeutic areas: Cytomegalovirus Retinitis, HIV Infections, Cryptosporidiosis.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cornell University A2201?

Cornell University A2201 has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cornell University A2201 conducted?

Cornell University A2201 has 22 clinical trials on record. Their work covers Cytomegalovirus Retinitis, HIV Infections, Cryptosporidiosis.

Is Cornell University A2201 accredited by Crixeo Health?

Yes — Cornell University A2201 holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Cornell University A2201?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.